Skip to main content
Immunovia logo

Immunovia — Investor Relations & Filings

Ticker · IMMNOV ISIN · SE0006091997 LEI · 549300KHWL6KK1XGUO81 ST Human health and social work activities
Open in API
Filings indexed 378 across all filing types
Latest filing 2025-10-20 Major Shareholding Noti…
Country SE Sweden
Listing ST IMMNOV

About Immunovia

https://immunovia.com/

Immunovia is a diagnostics company focused on revolutionizing the early detection of pancreatic cancer. Its primary product is the PancreaSure test, a simple blood test designed to detect pancreatic cancer at Stage 1 and 2 with high accuracy. The test is intended for annual surveillance of individuals at elevated risk due to family history or genetic mutations. PancreaSure functions by detecting proteins and other biomarkers indicative of pancreatic cancer growth. The company's mission is to improve survival rates for this highly lethal cancer by enabling diagnosis at its earliest, most treatable stages, offering a convenient alternative to invasive imaging procedures.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 100% confidence The document is a 'flaggningsmeddelande' (flagging notification) from the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding (crossing a threshold) by Avanza Bank Holding AB in Immunovia AB. This type of disclosure is a standard regulatory requirement for major shareholding notifications, which corresponds to the 'Major Shareholding Notification' category.
2025-10-20 Swedish
Sista dag för handel med teckningsrätter i Immunovias företrädesemission
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Immunovia AB regarding the final day of trading for subscription rights in a rights issue (företrädesemission). It details the timeline, terms of the offering, and provides legal disclaimers regarding the offering. It does not constitute a full prospectus or a financial report, but rather an announcement of a capital-raising event. Therefore, it falls under the category of Capital/Financing Update.
2025-10-16 Swedish
The last day of trading in subscription rights in Immunovia's rights issue
Share Issue/Capital Change Classification · 100% confidence The document is a press release announcing the final day of trading for subscription rights related to a rights issue by Immunovia. It details the mechanics of the rights issue, the timetable, and provides legal disclaimers regarding the offering. It does not contain the full prospectus or the financial report itself, but rather serves as an official announcement regarding the ongoing capital raising activity. Therefore, it is classified as a Capital/Financing Update.
2025-10-16 English
Immunovia publishes information document regarding rights issue
Share Issue/Capital Change Classification · 100% confidence The document is a press release announcing the publication and availability of an 'Information Document' related to a rights issue. It explicitly states that the company has prepared this document in accordance with the Prospectus Regulation and that it is now available on the company's website. Following the 'Menu vs Meal' rule, this is an announcement of a report/document rather than the report itself, making it a Report Publication Announcement (RPA).
2025-10-03 English
Immunovia offentliggör informationsdokument avseende företrädesemission
Share Issue/Capital Change Classification · 100% confidence The document is a press release announcing the publication of an 'Informationsdokument' (Information Document) related to a rights issue (företrädesemission). It explicitly states that the document is not a prospectus and provides links to where the information document can be found on the company's website. Following the 'Menu vs Meal' rule, this is an announcement of a report/document rather than the report itself, making it a Report Publication Announcement.
2025-10-03 Swedish
Kommuniké från extra bolagsstämma i Immunovia AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Kommuniké från extra bolagsstämma' (Communiqué from an Extraordinary General Meeting) for Immunovia AB. It details the specific decisions made during the meeting, including amendments to the articles of association and approval of a rights issue (företrädesemission). Since this document reports the official outcomes and resolutions of a shareholder meeting, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-09-29 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.